Oct 25, 2022
In this podcast, expert clinicians will discuss the promise of identifying and targeting the dominant cytokine networks active in the various disorders of IMID.
Oct 25, 2022
In this podcast, expert clinicians will review recent updates in the safety data regarding Janus kinase (JAK) inhibitors and discuss the appropriate selection of candidates for safe and effective use of JAK inhibitor therapy.
Oct 25, 2022
In this podcast, expert clinicians will discuss the safety and efficacy of interleukin-17/23 inhibitors for the management of inflammatory skin and joint diseases.